Wall Street analysts forecast that Teva Pharmaceutical Industries Ltd. (TEVA) will report quarterly earnings of $0.64 per share in its upcoming release, pointing to a year-over-year decline of 9.9$4.34 billion, exhibiting an increase of 2.6% compared to the year-ago quarter.The consensus EPS estimate for the quarter has been revised 2.2% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reev ...